Mercer Global Advisors
PROF

Mercer Global Advisors’s Profound Medical PROF Stock Holding History

Mercer Global Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5K Buy
+7,000
New +$47.1K ﹤0.01% 4352

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.59% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Mercer Global Advisors's PROF Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Profound Medical (PROF) in Q2 2026: 7,000 shares worth $46.5K. The stake represents ﹤0.01% of the portfolio and ranks #4352 among its holdings.

54 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Mercer Global Advisors held 7,000 shares of Profound Medical worth $46.5K as of Q2 2026.
  • Profound Medical was a new Mercer Global Advisors position in Q2 2026.
  • Profound Medical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4352 holding.
  • 54 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.